Glaucoma Drainage Devices Market Performance Outlook 2026–2030: Revenue to Hit $1.42 Billion at 9.7% CAGR
Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
What long-term size projections exist for the Glaucoma Drainage Devices Market covering 2026–2035?
The glaucoma drainage devices market size has experienced substantial expansion in recent years. Its value is anticipated to rise from $0.89 billion in 2025 to $0.98 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.0%. The historical growth of this market can be attributed to the increasing prevalence of glaucoma, the expansion of ophthalmic surgical centers, the growing adoption of surgical glaucoma treatments, a rising aging population, and the availability of specialized eye care facilities.
The glaucoma drainage devices market is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $1.42 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.7%. This expansion during the forecast period can be attributed to the escalating demand for minimally invasive eye surgeries, increased investments in ophthalmic device innovation, the broadening of advanced glaucoma care programs, a heightened focus on early intervention, and technological advancements in implant materials and design. Significant trends expected in this period include the increased adoption of minimally invasive glaucoma implants, a rising demand for valved drainage devices, an intensified emphasis on long-term intraocular pressure control, the proliferation of advanced biocompatible materials, and enhanced precision in surgical implant design.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20821&type=smp
Which Drivers Are Impacting The Competitive Landscape Of The Glaucoma Drainage Devices Market?
The growing occurrence of glaucoma is anticipated to fuel the expansion of the glaucoma drainage devices market in the future. Glaucoma refers to a collection of eye ailments that harm the optic nerve, commonly stemming from elevated intraocular pressure, which can lead to permanent vision loss if left untreated. The surge in glaucoma diagnoses is linked to multiple elements including an older demographic, increasing urbanization, and evolving lifestyle habits. These devices assist in regulating intraocular pressure in cases of refractory glaucoma by promoting the drainage of aqueous humor when standard therapies prove ineffective. As an illustration, in October 2025, The NHS Confederation, a UK-based membership organization, stated that glaucoma, which is the primary reason for irreversible vision loss in the UK, impacts over 700,000 people; almost half of these individuals are undiagnosed because the condition often lacks symptoms and hospital waiting lists are extensive. NHS waiting periods can extend to 72 weeks, and significant eye conditions are forecasted to increase by 25% between 2022–2032, a growth rate seven times faster than population expansion. Consequently, the increasing occurrence of glaucoma conditions is propelling the growth of the glaucoma drainage devices market. The development of healthcare infrastructure is projected to boost the growth of the glaucoma drainage devices market in the future. This infrastructure encompasses the interconnected system of hospitals, clinics, diagnostic facilities, and ancillary medical sites that ensure quality healthcare services are available to the public. The enlargement of healthcare infrastructure is fueled by greater investments from both government and private sectors, an expanding population, and an increasing need for sophisticated medical care. Enhanced infrastructure facilitates the integration of novel medical technologies, improves patient access to treatments, and optimizes the effectiveness of healthcare provision. For example, in May 2023, a report from the Office for National Statistics, a UK-based government department, indicated that UK healthcare spending between 2022 and 2023 rose by 5.6%, a notable increase compared to the 0.9% growth observed in 2022. In 2023, the total healthcare expenditure in the UK reached approximately $317.63 billion (£292 billion). Consequently, the expansion of healthcare infrastructure is stimulating growth within the glaucoma drainage devices market.
What Leading Segments Are Studied In The Glaucoma Drainage Devices Market?
The glaucoma drainage devices market covered in this report is segmented –
1) By Product Type: Valved Glaucoma Drainage Devices, Non-Valved Glaucoma Drainage Devices
2) By Surgery Type: Conventional Glaucoma Surgery, Minimally Invasive Glaucoma Surgery
3) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Valved Glaucoma Drainage Devices: Ahmed Glaucoma Valve, Baerveldt Glaucoma Implant, Krupin Implant, Others
2) By Non-Valved Glaucoma Drainage Devices: Molteno Implant, Schocket Implant, Foster Implant, Others
Which Trends Are Influencing The Development Of The Glaucoma Drainage Devices Market?
Leading firms within the glaucoma drainage devices market are concentrating their efforts on creating advanced canal-based glaucoma surgery devices. This initiative aims to provide less invasive choices and cater to the increasing need for treatments that are both safer and more effective. These canal-based glaucoma surgery devices are implants specifically designed to target Schlemm’s canal, thereby improving aqueous humor drainage and consequently lowering intraocular pressure (IOP). This mechanism aids in managing glaucoma by directly tackling the main factor contributing to the disease’s advancement. As an illustration, in March 2023, Nova Eye Medical Limited, an Australia-based glaucoma devices manufacturer, obtained clearance for its iTrack Advance canaloplasty device. This cutting-edge device is engineered for the processes of microcatheterization and viscodilation, intended to decrease intraocular pressure (IOP) in adult patients diagnosed with primary open-angle glaucoma. The iTrack Advance incorporates an ergonomic handpiece and upgraded technology, designed to boost surgical efficiency. Its design accommodates both independent surgical procedures and those carried out concurrently with cataract surgery.
Which Key Market Players Are Investing In Expansion And Innovation Within The Glaucoma Drainage Devices Market?
Major companies operating in the glaucoma drainage devices market are AbbVie Inc., Alcon Inc., Johnson And Johnson Vision Care Inc., Santen Pharmaceutical Co. Ltd., Glaukos Corporation, Ocular Therapeutix Inc., IRIDEX Corporation, New World Medical Inc., Ivantis Inc., iSTAR Medical, Nova Eye Medical Limited, Altomed, Aurolab, G.surgiwear Limited, Eagle Vision Inc., Advanced Ophthalmic Innovations Pte Ltd., Avisi Technologies Inc., iVeena Delivery Systems, Optonol Ltd., Rheon-medical
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/glaucoma-drainage-devices-global-market-report
Which Regions Are Poised For Strategic Growth In The Glaucoma Drainage Devices Market?
North America was the largest region in the glaucoma drainage devices market in 2025. The regions covered in the glaucoma drainage devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Glaucoma Drainage Devices Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20821&type=smp
Browse Through More Reports Similar to the Global Glaucoma Drainage Devices Market 2026, By The Business Research Company
Minimally Invasive Glaucoma Surgery Migs Devices Global Market Report 2026
Medical And Surgical Drainage System Global Market Report 2026
Cataract Surgery Devices And Equipment Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
